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Summary
The Escherichia coli serotype O9a O-antigen polysac-
charide (O-PS) is a model for glycan biosynthesis and
export by the ATP-binding cassette transporter-
dependent pathway. The polymannose O9a O-PS is
synthesized as a polyprenol-linked glycan by manno-
syltransferase enzymes located at the cytoplasmic
membrane. The chain length of the O9a O-PS is tightly
regulated by the WbdD enzyme. WbdD first phospho-
rylates the terminal non-reducing mannose of the
O-PS and then methylates the phosphate, stopping
polymerization. The 2.2 Å resolution structure of
WbdD reveals a bacterial methyltransferase domain
joined to a eukaryotic kinase domain. The kinase
domain is again fused to an extended C-terminal
coiled-coil domain reminiscent of eukaryotic DMPK
(Myotonic Dystrophy Protein Kinase) family kinases
such as Rho-associated protein kinase (ROCK). WbdD
phosphorylates 2-a-D-mannosyl-D-mannose (2a-MB),
a short mimic of the O9a polymer. Mutagenesis iden-
tifies those residues important in catalysis and sub-
strate recognition and the in vivo phenotypes of these
mutants are used to dissect the termination reaction.
We have determined the structures of co-complexes of
WbdD with two known eukaryotic protein kinase
inhibitors. Although these are potent inhibitors in
vitro, they do not show any in vivo activity. The struc-
tures reveal new insight into O-PS chain-length regu-
lation in this important model system.
Introduction
Most Gram-negative bacteria contain lipopolysaccharide
(LPS) as a major component of the outer membrane. LPS
consists of a well-conserved anchor, lipid A, linked to a
hypervariable strain-specific O-antigen polysaccharide
(O-PS) (over 180 in Escherichia coli) (Stenutz et al., 2006)
via a short core oligosaccharide (Raetz and Whitfield,
2002). LPS mediates critical interactions with the host
immune defences and the presence of O-PS plays a role in
resistance to complement-mediated killing (Joiner, 1988).
Although the structures of O-PSs are extremely diverse,
they are made by one of three types of O-PS biosynthesis
systems; the ‘Wzx/Wzy dependent’, the ‘ATP-binding cas-
sette (ABC) transporter dependent’ and the poorly studied
‘synthase dependent’ pathways (Raetz and Whitfield,
2002). In each case, the length of the O-PS is tightly
controlled and exhibits a defined range of chain lengths
(termed ‘modal’ distribution) (Fig. 1A). The polymannose
O-PSs of E. coli serotypes O8, O9 or O9a are prototypes
for the ‘ATP transporter dependent’ pathway of O-PS syn-
thesis (Fig. 1B). In this system, the WecA enzyme syn-
thesizes a ‘primer’ comprising undecaprenol-diphospo-
GlcNAc (und-PP-GlcNAc) and the polymannose O-PS is
synthesized and extended by the mannosyltransferases
WbdA, WbdB and WbdC (Greenfield et al., 2012). The
length of the polymannose chain in E. coli O9 (and O9a) is
controlled by a termination reaction, whereby a phosphate
followed by a methyl group is added to the 3-OH position of
the non-reducing terminal mannose residue of the chain
(Clarke et al., 2004; 2011) (Fig. 1A). In contrast, in E. coli
O8 a methyl group is added to the 2-OH of the reducing
mannose without phosphorylation (Vinogradov et al.,
2002; Clarke et al., 2004). These modifications block
further polymerization and are retained in the mature O-PS
structure (Vinogradov et al., 2002; Kubler-Kielb et al.,
2012). The terminating and chain length regulating modi-
fications are catalysed by the strain-specific WbdD pro-
teins. The O9/O9a WbdD homologue is a bifunctional
kinase-methyltransferase, whereas the O8 WbdD is a
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Fig. 1. Function and structure of WbdD.
A and B. (A) Overview of the biosynthesis and export (B) of the O9a O antigen. The polymannose glycan is synthesized by three
mannosyltransferases with different roles in the overall process (WbdCBA). Together, WbdCB add three Man residues to the
undecaprenyl-PP-GlcNAc acceptor formed by the initiating WecA enzyme. The resulting lipid-linked oligosaccharide is then extended by the
polymerizing WbdA enzyme to build the repeat-unit polysaccharide. Chain extension is terminated by the dual kinase/methyltransferase
activity of WbdD. Terminated polysaccharides are recognized by the carbohydrate-binding module linked to the nucleotide-binding domain
(Wzt) of the ABC transporter and are exported to the periplasmic face of the inner membrane, presumably via a channel formed by the
transmembrane polypeptide (Wzm). The details of the transport process have not been resolved. Once exported, the nascent O antigen is
transferred from its undecaprenyl-PP carrier to the lipid A-core part of LPS (which is synthesized and exported separately) and the completed
molecule is translocated to the cell surface via proteins in the Lpt pathway.
C. Domain boundaries of WbdD.
D. The trimeric structure of WbdD556, shown as a cartoon model with a colour gradient running form blue (N-terminus) to purple (C-terminus).
The cofactors are depicted as spheres (atom colouring: C-orange, N-blue, O-red, P-light orange). The proposed structure of the C-terminal
three-helix bundle is indicated by coloured tubes.
E. Topology diagram of WbdD556. Strands are represented by triangles, helices by tubes. The colour scheme is identical to (D).
F. Superposition of the kinase domains of WbdD556 (coloured as in Fig. 2) and WbdD459 (grey). The ATP cofactor is shown as spheres.
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simple methyltransferase (Clarke et al., 2004; 2011). The
WbdD protein has been shown to recruit the critical WbdA
mannosyltransferase to the membrane via protein:protein
interactions mediated by the C-terminal (non-catalytic)
region of WbdD (Clarke et al., 2009). Chain termination by
WbdD is essential for export; E. coli O9a wbdD mutants
can synthesize the unmodified O9a polysaccharide but are
unable to export it (Cuthbertson et al., 2005; 2007). This
phenotype reflects a quality-control process (Cuthbertson
et al., 2007; 2010) ensuring that only O-PS glycans of
defined chain lengths are exported and WbdD is the
master-regulator in the system. Comparable assembly
systems are exploited in the biosynthesis of other O-PSs in
various bacteria and in assembly of O-linked glycans in
Gram-positive bacteria (Cuthbertson et al., 2010).
Here, we report the 2.2 Å crystal structure of the
bi-functional catalytic domain of the WbdD protein from
E. coli O9a. Our data show the two domains are arranged
to produce the unique methyl-phosphate modification on
the 3-OH of the non-reducing terminal mannose. Most
surprisingly, the kinase domain adopts a fold thought con-
fined to eukaryotic tyrosine kinase. The structural infor-
mation allows us to selectively disable the individual
domains by site-directed mutagenesis. We have investi-
gated the resulting phenotypes in vivo in addition to in
vitro enzymatic activity. We report co-crystal structures
and in vitro potency for inhibitors of the kinase domain of
WbdD. The data gives important new insights into the




The 82 kDa WbdD protein from E. coli O9a (Fig. 1A and
C) comprises 708 residues and contains three domains,
an N-terminal methyltransferase (MTase) domain, a
kinase domain and a C-terminal domain (residues 460–
708) that includes predicted coiled-coil motifs (Clarke
et al., 2004) (Fig. 1C). The full-length WbdD protein was
not tractable for biophysical characterization but a 63 kDa
fragment, comprising residues 1–556 (WbdD556), could
be expressed, purified and crystallized (Hagelueken
et al., 2012). Crystal optimization by dehydration and
structure solution are detailed elsewhere (Hagelueken
et al., 2012). The 2.2 Å structure was refined using
REFMAC5 (Murshudov et al., 1997) (Fig. 1D). The Rfree
and R-factors converged at 17.9%/22.2% and the geom-
etry of the model was checked and optimized using MOL-
PROBITY (Chen et al., 2010). Crystallographic data are
summarized in Table 1.
The WbdD556 structure has an elongated shape with
an N-terminal MTase domain (residues 1–210) directly








Space group I23 I23 I23 P212121
Unit cell (Å, °) a = b = c = 159.2,
a = b = g = 90
a = b = c = 159.0,
a = b = g = 90
a = b = c = 159.5,
a = b = g = 90
a = 40.7, b = 89.6,
c = 135.5, 3 = b = g = 90
Matthews coefficient (Å3*Da-1) 2.8 2.8 2.8 2.5
Solvent content (%) 55.8 55.6 56 50.3
Molecules per ASU 1 1 1 1
Wavelength (Å) 0.9686 1.5417 0.9795 0.9173
Beamline I04 Inhouse I04 I04-1
Resolution range (Å) 65.0 - (2.21 - 2.15) 42.5 - (2.40 - 2.34) 112.8 - (3.32 - 3.24) 67.7 - (2.53 - 2.47)
Total observations 402776 246972 63966 119284
Unique reflections 36526 27997 10923 18171
Completeness (%) 100 (100) 99.3 (91.3) 99.9 (100) 98.5 (95.0)
Rmerge 0.09 (0.1) 0.06 (0.41) 0.12 (0.70) 0.08 (0.75)
Multiplicity 11 (11.2) 8.8 (2.8) 5.9 (6.0) 6.6 (6.1)
I/s/I 19.3 (3.2) 27.1 (2.4) 11.5 (2.6) 19.3 (3.1)
Refinement
Resolution range (Å) 65.0–2.15 112.4–2.34 112.8–3.29 67.7–2.47
R/Rfree (%) 17.9/22.2 18.8/25.5 22.3/26.5 19.3/23.7
R.m.s.d. bonds (Å)/angles (°) 0.013/1.68 0.014/1.78 0.008/1.36 0.014/1.67
Ramachandran plot
(% favoured/disallowed)
97.2/0.2 95.6/0.9 97.3/0.2 97.3/0.3
MOLPROBITY (Chen et al.,
2010) score/clash score
1.91/8.33 2.38/14.41 2.01/10.79 2.09/10.19
Values in parenthesis refer to the highest resolution shell.
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adjacent to the kinase domain (residues 211–459)
(Fig. 1C–E). WbdD556 is a trimer in the crystal, consistent
with its status in solution as judged by gel-filtration
(Fig. S1). The C-terminal a-helix (aV) (residues 459–473)
of each monomer wraps around the crystallographic
threefold axis forming a trimeric bundle reminiscent of a
coiled-coil (Fig. 1D). Residues 474–556 are disordered,
possibly because of packing constraints (Hagelueken
et al., 2012) but are predicted to be helical. Removing this
C-terminal helix (WbdD459) gave a monomeric protein in
crystals (space group P212121, Table 1) and in solution
(Fig. S1), confirming that the helical bundle drives trimer
formation. The structures of WbdD459 and monomers
of WbdD556 are very similar [r.m.s.d. = 1.5 Å (2538
superimposing atoms)], but there is a rigid-body rotation
around the hinge connecting the N- and C-lobe within the
kinase domain, accounting for the relatively large r.m.s.d.
(Fig. 1F).
The methyltransferase domain is specific to a
phosphate attached to 2-a-D-mannosyl-D-mannose
The MTase domain of WbdD consists of a seven-stranded
b-sheet with the characteristic (for MTases) reversed
b-hairpin (b6-b7) at the C-terminus of the sheet, which is
surrounded by a-helices on either side (Fig. 1E). The fold
belongs to group 1 according to a classification system for
methyltransferases proposed by Schubert et al. (2003).
NodS from Bradyrhizobium japonicum (Cakici et al., 2010)
and RebM of Lechevalieria aerocolonigenes (Singh et al.,
2008) are the most similar structures (NodS: Z-score 16.0,
r.m.s.d. 2.7 Å; RebM: Z-score 15.6, r.m.s.d. 2.8 Å). The
S-adenosylmethionine (SAM) binding site located on top of
the b-sheet (Fig. 2A and B) is much more exposed in
WbdD than seen in NodS (Cakici et al., 2010) (Fig. S2).
Positively-charged residues (R203, H132 and H133)
cluster around the electrophilic methyl group, consistent
Fig. 2. The MTase domain of WbdD556.
A. Close up of the active site. The SAM cofactor (purple) and selected active-site residues are shown as ball-and-sticks models.
B. Electrostatic surface potential of the MTase active site (blue-positive, white-neutral, red-negative). The SAM cofactor (purple ball-and-sticks)
and selected active-site residues are numbered.
C. The sulphate binding site is close to the MTase active site (colour scheme as Fig. 3B).
D. Sequence alignment (CLUSTALW) of the WbdD enzymes from E. coli O9a and O8 (no kinase domain).
Residues that are shown in (A), (B) and (C) are indicated and highlighted in red.
Crystal structure of E. coli WbdD 733
© 2012 Blackwell Publishing Ltd, Molecular Microbiology, 86, 730–742
with a phosphate binding site (arising from the phosphor-
ylated sugar substrate) (Fig. 2A–C). R203 is not structur-
ally conserved in NodS or RebM and the two His residues
are found as either two His or two Tyr in these two proteins
(Fig. S2).
The MTase reaction was analysed by NMR using 1H,31P-
HMBC correlation spectra and the kinase substrate
2a-mannobiose (2a-MB) (Fig. 3A). A cross-peak at
dH = 4.14 ppm dP = 4.1 ppm indicated formation of phos-
phorylated 2a-MB. A new phosphorus resonance at
dP = 1.0 ppm appeared after SAM was added to the reac-
tion establishing methylation of the 3-phosphate group
(Fig. 3A); consistent with previous studies using polymeric
material (Clarke et al., 2011; Kubler-Kielb et al., 2012).
No such cross-peak appears when D-mannose-3-phos-
phate (monomer), D-mannose-1-phosphate, D-mannose-
6-phosphate, D-glucose-1-phosphate or phosphate were
added to the reaction, demonstrating the methyltrans-
ferase activity is specific to phosphate attached to the
3-position of the disaccharide. Mutant WbdD556 proteins
(H132A, H133A, R203A, Y16F) were able to phosphor-
ylate 2a-MB but no MTAse reactivity was detected in vitro
(Fig. 3B).
Unlike other structurally characterized MTase proteins,
WbdD has a pocket lined by R31, R36, N34, Q35, C33,
F194, D195 and H197 adjacent to the active site. The
pocket is occupied by sulphate in the WbdD556 structure,
these crystals were grown from ammonium sulphate solu-
tions (Fig. 2A and C) whereas the pocket is empty (with the
loops disordered) in WbdD459 crystals which were grown
from a non-sulphate-containing solution (Fig. S3). Running
the identical NMR-based methylation assay with Wb556 in
250 mM sulphate reduces the reaction rate by 50% and in
1 M sulphate (similar to crystallization condition) the rate is
down to < 10% (Fig. 3C). A triple N34D, Q35E and H197E
mutant [constructed to disrupt the sulphate-binding pocket
(Fig. 2C)] has less than 10% of the wild-type reaction rate
(Fig. 3B).
The kinase domain of WbdD resembles
eukaryotic kinases
In the kinase domain of WbdD, the N- and C-lobes are
separated by an ATP binding cleft (Fig. 1C–F). The DALI
server (Holm and Rosenström, 2010) identifies a strong
structural similarity to well-studied eukaryotic kinases
including the Src kinase [PDB-id: 2SRC, Z-score: 12.2,
r.m.s.d.: 3.3 Å, length of alignment: 182 residues (Xu et al.,
1997)], ROCK (Jacobs et al., 2006), Lck (Yamaguchi and
Hendrickson, 1996) and Erk (Canagarajah et al., 1997)
(Fig. 4A). The overall sequence identity between the
kinase domains of WbdD and human Src is very low,
with 11% over 295 aligned residues. Interestingly, Src
(PDB: 2SRC) superimposes more closely on WbdD459
(r.m.s. = 3.3 Å (350 Ca atoms) than on WbdD556
[r.m.s. = 5.6 Å (350 Ca atoms)].Although the characteristic
structure of the catalytic loop is conserved in WbdD
(Fig. 4A), superposition of Src and WbdD459 reveals that
two other key features of eukaryotic kinases (Endicott
et al., 2012), the ‘G-rich’ loop (b10–b11 in WbdD) and the
activation loop (b16–aQ in WbdD) are different in WbdD
(Fig. 4A). Of our structures, the ‘G-rich’ loop is most clearly
defined in the Wbd459 structure, where it fulfils the same
role as in Src; co-ordination of the AMPPNP (ATP mimic).
However, in WbdD the loop protrudes further into the ATP
binding cleft than the corresponding element in Src
(Fig. 4A) and it interacts with the catalytic loop through a
p-stacking between W355 and Y230 (Fig. 4B). The ‘activa-
tion loop’ of Src contains a regulatory tyrosine residue that
can be autophosphorylated to activate the kinase. In
WbdD, the corresponding loop (b16–aQ) is much shorter,
Fig. 3. In vitro and in vivo analysis of the MTase activity of WbdD.
A. Monitoring activity of WbdD by 1H,31P-HMBC correlation. The
cross-peak dH = 4.14 ppm dP = 4.1 ppm indicates formation of
phosphorylated 2a-MB. A new phosphorus resonance at 1.0 ppm
appears after adding SAM. Two corresponding cross-peaks
(dH = 3.47 and 4.11 ppm) are in accordance with 2a-MB methyl
phosphate having two non-equivalent hydrogen atoms in distance
of three bonds from phosphorus.
B. Table of NMR results for different mutants. Figure S6 shows that
the MTase mutants are still capable of phosphorylating 2a-MB.
C. The influence of sulphate on the reaction velocity in vitro.
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lacks tyrosine and is partly disordered in all of our struc-
tures (Fig. 4A and B). The C-terminal helix aV of WbdD
(three-helix bundle) is a structural permutation of the
eukaryotic kinase fold and occupies a similar position as
the aG helix of Src (Fig. 4A) that stabilizes the activation
loop in Src.
WbdD binds ATP (or AMPPNP) via two Mg2+ ions
(denoted Mg1, Mg2) that are co-ordinated by N356, D369
[part of the DFG motif which is almost universally con-
served in kinases (Kannan et al., 2007; Endicott et al.,
2012)], E274 and all three phosphate groups of ATP (or
AMPPNP), as well as by two water molecules (Fig. 4B).
Mg1 bridges the a- and g-phosphates, Mg2 the b- and
g-phosphates. This co-ordination resembles that seen in
cAMP-dependent protein kinases (Zheng et al., 1993a;
1993b)
Substrate specificity of the kinase activity of WbdD
WbdD556 has a marked preference for 2a-MB over
D-Mannose with respective KM values of ~ 0.7 mM versus
> 100 mM (Fig. 5A). Different disaccharide variants (3-a-,
4-a- and 6-a-mannobiose) are also substrates, but at
~ 80% reduced reaction rates (when compared at KM of
2a-MB, Fig. S4A and B). D-glucose, D-galactose, kojibi-
ose (a(1→2)D-glucosyl-D-glucose), lactose [b(1→2)D-
galactosyl-D-glucose] and maltose [a(1→4)D-glucosyl-D-
glucose] are not substrates (Fig. S4B). NMR analysis
established that WbdD556 phosphorylates 2a-MB at the
3-hydroxyl of the non-reducing sugar, identical to the
authentic substrate (Clarke et al., 2011; Kubler-Kielb
et al., 2012). Similar experiments were conducted with
D-mannose, 3-a-, 4-a- and 6-a-mannobiose and indicate
these compounds are also phosphorylated at the 3-
hydroxyl of the non-reducing sugar (Fig. S4C). WbdD459,
which lacks the C-terminal bundle-helix aV (Fig. 1C–F),
showed a marked decrease in kinase activity but has lost
the preference for 2a-MB over D-mannose (Fig. S4D and
E). Thus, the C-terminal bundle structure is clearly impor-
tant both for biochemical activity and for polymer (sub-
strate) recognition or co-ordination. We speculate that the
C-terminal bundle interacts with and stabilizes active-site
features, such as the activation loop (b16/aQ) or loop
aQ/aR, which are disordered in our structures (see below,
Fig. 6A).
Mutational analysis of the kinase substrate (acceptor)
binding site
Attempts to co-crystallize WbdD556 with 2a-MB were
unsuccessful, potentially because of the rigid body
movements occurring in the structure during dehydration
(Hagelueken et al., 2012). We therefore attempted to
co-crystallize WbdD556 and WbdD459 with D-mannose
(KM > 100 mM) by soaking our crystals in saturated
D-mannose solutions (~ 1.6 M). Only WbdD459 crystals
(with AMPPNP) withstood the treatment and gave addi-
tional electron density (not present before addition of
Fig. 4. Analysis of the kinase domain of WbdD.
A. Superposition of WbdD459 and human Src kinase (grey). The signature motifs of Src-kinase such as the catalytic loop, the activation loop
(A-loop) and the Gly-rich loop are highlighted in red, the position of the C-helix is indicated. Helices are pictured as cylinders and the colour
scheme is as in Fig. 1.
B. Selected active-site residues of WbdD (the WbdD459 structure is shown) are shown as sticks. The start- and end-points of disordered
loops (activation loop b16-aQ and aQ-aR) are marked by spheres and the loops are represented as dashed lines.
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D-mannose) that we interpret as two mannose units,
Fig. 6A. The relatively poor quality of this density is con-
sistent with the anticipated weakness of the interaction.
However, it allowed us to identify amino acids surround-
ing the active site for mutagenesis (Fig. 6A and B). The
D351E/A mutations and the Y230F mutation completely
eliminated activity in vitro. Mutation of W355 to F had
very little effect on catalysis, whereas W355H showed
a ~ 50% reduction of activity. These data are consistent
with a structural model where substrate is bound by the
hydroxyl of Y230 and the carboxylate of D351. However,
since D351 also ligates the Mg1 ion, its mutation may
also disrupt catalysis. W355 does not play a catalytic
role and we suggest instead that it helps to anchor the
side-chain of Y230 by a p-stacking interaction (Figs 4B
and 6A). The R270A and E274A mutations target resi-
dues that are distant from the non-reducing mannose
unit (which is phosphorylated) but are predicted to rec-
ognize the second sugar molecule. Indeed, the mutants
lead to a more pronounced loss of activity towards
2a-MB compared with mannose (Fig. 6A and B). Dele-
tion of either the C-terminal bundle helix (WbdD459, see
above), or loop aQ–aR, severely attenuates the activity
of WbdD against both 2a-MB and D-mannose and com-
pletely removes any preference for the polymeric sub-
strate (Fig. S4C and D, Fig. 6A and B).
Kinase-dead mutants such as D351A lead to a com-
plete abrogation of O-PS synthesis in vivo, comparable to
the DwbdD strain (Fig. 6C). D350A which showed a 10%
decrease in activity in vitro (Fig. 6B) shows a shift to
longer chain length in vivo, combined with a decrease in
the amount of polymer that is expressed on the surface
(Fig. 6C). These characteristics are the anticipated result
of a mutation with reduced catalytic activity that simulta-
neously affects the ability to control chain length appro-
priately and reduces the terminated product available for
recognition and export by the ABC transporter (Clarke
et al., 2004; Cuthbertson et al., 2007).
WbdD is inhibited by small-molecule inhibitors of
eukaryotic kinases
Approximately 1000 different kinase inhibitors were
screened from collections obtained from GlaxoSmithKline
and the International Centre for Kinase Profiling (Dundee,
UK). IC50 values were determined for GW435821x
(7.8 mM), LY294002 (68 mM), Butein (182 mM), IKK inhibi-
tor VII (1.2 mM) and indirubin (> 100 mM; estimated due to
low solubility) (Fig. 7A and B). Co-complex structures of
the two best inhibitors GW435821x and LY29004 were
solved at 3.3 Å and 2.3 Å resolution respectively (Fig. 7C
and D, Table 1). Both compounds occupied the ATP-
binding cleft and interacted with the protein via multiple
hydrophobic and vdW interactions. GW435821x is also
bound by three hydrogen bonds to D318, the backbone
oxygen of E309, and K310. LY294002 only makes a
single polar interaction to the backbone nitrogen of K310
(Fig. 7D), consistent with its lower affinity. None of the
Fig. 5. Kinase activity.
A. Enzyme kinetics of the WbdD556 kinase reaction. The reaction velocity in arbitrary units (ADP glo signal, Promega) is plotted against the
concentration of D-mannose and 2a-MB. Data points were measured in triplicate and error bars represent the standard deviation of the
measurements. Solid lines are non-linear fits to the data points using the function y = offset + Vmax  {x/[Km + x  (1 + x/Ki)]}.
B. 1H,1H-COSY spectrum of the product yielded by phosphorylation reaction of 2a-MB with WbdD556 and ATP-D6. The red dashed line
highlights the step-wise correlation between H1, H2 and H3 resonances of the non-reducing sugar. The resonance at 4.14 ppm (H3) shows
coupling to phosphorus in 1H,31P-HMBC correlation identifying the product as 2a-MB-3-phosphate.
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inhibitor compounds tested affected either growth or the
O-PS phenotype of E. coli O9a [CWG634 (Clarke et al.,
2004)], even when cells were grown in the presence
of sub-inhibitory concentrations of EDTA in an attempt
to permeabilize the cell envelope. Our data do not
reveal the reason for the lack of activity but lack of
uptake, rapid efflux or metabolism provide some potential
explanations.
Discussion
Regulation of carbohydrate polymerization and export is
vital to bacterial pathogenesis. The E. coli O9a system is
an important prototype for these processes in ABC
transporter-dependent glycan biosynthesis (Cuthbertson
et al., 2010). Phosphorylation by WbdD is sufficient to
terminate the glycan chains (Clarke et al., 2011) and
we have shown here that WbdD mutations which reduce
the kinase activity in vitro lead to much longer O-PS
chain lengths in vivo (e.g. WbdD D350A, Fig. 6C). In the
absence of all phosphorylation, no O-PS is seen on the
cell surface (WbdD D351A, Fig. 6C) because the termi-
nal modification is essential for recognition of the
nascent glycan by the carbohydrate-binding module
attached to the ABC transporter (Cuthbertson et al.,
2007).
WbdD is an unusual enzyme since it combines both a
phosphate-methyltransferase and a sugar kinase activity.
Whereas the more common 6- or 1-mannose-phosphates
are produced by mannokinase and phosphomanno-
mutase respectively (Sebastian and Asensio, 1972; Sugi-
yama et al., 1994), WbdD is a unique and highly specific
eukaryotic-like kinase targeting the 3-OH position of
D-mannose and D-mannose-based polysaccharides, with
a particular preference for a(1→2) linked mannose units.
Site-specific phosphorylation of sugar polymers are diffi-
cult to achieve chemically and our results show that
WbdD can tolerate a number of different mannose-
containing disaccharides while regio-selectively phospho-
rylating the 3-OH. Although existence of eukaryotic-like
Fig. 6. Mutagenesis of the WbdD kinase active site.
A. Additional electron density that was found after the crystals were
soaked with D-mannose is shown as blue mesh (2Fo-Fc, 1 s) and
green mesh (Fo-Fc, 3 s). Two D-mannose residues are tentatively
modelled into the density to show that the size of the density is
consistent with two D-mannose units. WbdD is highlighted
corresponding to influence of mutations at these points on the
activity of the enzyme: red – < 5% WT activity, blue – ~ 50%
reduced activity, grey – 90–100% of wild-type activity.
B. The relative activity of WbdD mutants for 2a-MB and
D-mannose. Values are given in % and correspond to averages of
triplicate measurements. The values for 2a-MB and D-mannose
were independently scaled to 100.
C. Silver-stained LPS SDS-PAGE showing restoration of O9a O-PS
biosynthesis in an E. coli O9a wbdD mutant overexpressing
His6-WbdD and two kinase active-site mutants.
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kinases in prokaryotes is known (Kannan et al., 2007),
structural information is still sparse (Table S1). Examples
include the aminoglycoside kinase APH from Enterococ-
cus faecalis (Hon et al., 1997), the stress response regu-
lator Ser/Thr kinase YihE from E. coli (Zheng et al.,
2007), and the transmembrane signalling Ser/Thr kinase
PknB from Mycobacterium tuberculosis (Young et al.,
2003). Among bacteria, close homologues of the WbdD
kinase domain are found in some E. coli strains and
related enterobacteria (Klebsiella, Salmonella, Sodalis,
Pantoea), as well as several Xanthomonas species.
Although WbdD is structurally similar to the Src kinase
(Fig. 4A) it does not easily fit into a sequence-based
classification of kinases (Kannan et al., 2007), rather it
shares some similarities with the PknB family, and with
KdoK [3-deoxy-D-manno-octulosonic acid (Kdo) kinase]
(White et al., 1999). The degree of evolutionary diver-
gence of WbdD even from these kinases is obviously
rather large, hindering attempts to draw firm conclusions
about its evolutionary origin. The structural similarity
shared with human kinases is emphasized by our identi-
fication of several known tyrosine kinase inhibitors that
also inhibit WbdD. As expected the inhibitors bind in the
ATP binding cleft.
The domain architecture of WbdD (eukaryotic-kinase
followed by a long coiled-coil and a C-terminal protein–
Fig. 7. Inhibition of WbdD by tyrosine kinase inhibitors.
A. Chemical structures of compounds that inhibit WbdD.
B. IC50 analysis of the compounds shown in (A). Indirubin is not shown, since no IC50 data could be produced due to solubility issues.
C. Co-crystal structure of WbdD with GW435821x. The inhibitor and selected residues are indicated as ball-and-stick. The blue mesh is a
2DFo-mFc omit density at 1 s, the green mesh a DFo-mFc omit density at 3 s.
D. Co-crystal structure of WbdD with LY294002; representation as (C).
Stereo pairs for (C) and (D) are in Fig. S7.
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protein interaction domain) (Clarke et al., 2004; 2009) is
strikingly similar to DMPK (Myotonic Dystrophy Protein
Kinase)-family kinases such as ROCK (Rho-associated
protein kinase). ROCKs are large (160 kDa), dimeric mul-
tifunctional protein serine/threonine kinases that regulate
eukaryotic cell motility. ROCKs comprise a short N-
terminal dimerization domain, a kinase domain, a long
(~ 680 AA) coiled-coil domain followed by a Rho-binding
(RB) domain and a pleckstrin homology (PH) domain
(Riento and Ridley, 2003). The crystal structures of ROCK
I and a proteolytic fragment of its coiled-coil domain have
been solved in isolation (Jacobs et al., 2006; Tu et al.,
2011), so that it is not yet clear how the structural elements
are connected to each other (Tu et al., 2011). The commo-
nality in structure however could suggest that WbdD might
be an important evolutionary link between ROCK kinases
and their relatives of bacterial origin (Fig. S5).
The MTase reaction is very unusual and we have
shown it to be specific for di-mannose 3-phosphate-
containing acceptors. To our knowledge, the MTase
domain of WbdD is the first phosphate MTase to be struc-
turally characterized and it provides potential opportuni-
ties in biotransformation. The WbdD homologue from
E. coli O8 lacks a kinase domain and simply methylates
sugar hydroxyls directly and, as a consequence, the
sequence similarity between the proteins is relatively
limited. WbdD residues Arg36 and Asp82 that interact with
the SAM donor are conserved in both proteins (Fig. 2A
and D) but the positively charged residues Arg203,
His132 and His133, which are all essential for the MTase
activity of the O9a enzyme, have no equivalent in the O8
enzyme (or in other known sugar MTases) (Fig. 2A, B and
D, Fig. S2). It is these residues that we identify as confer-
ring the ability to process a phosphate nucleophile. It
remains unclear why E. coli O9a employs a bi-functional
WbdD enzyme when the simpler methyltransferase-only
homologue suffices for E. coli O8.
The O9a system provides an elegant solution to the
requirement for quality control in the chain length of bac-
terial glycans. The C-terminal coiled-coil domain of WbdD
is essential for the recognition of correct polymeric sub-
strate (over simple monosaccharide), important for kinase
activity and required for trimer formation. Since the
C-terminal region of the protein also recruits the WbdA
mannosyltransferase (Clarke et al., 2009), we suggest that
the C-terminal helix underpins the regulation of the
polysaccharide chain length. The binding of substrate or
product by WbdD could for example induce a conforma-
tional change, which is transmitted by the C-terminal helix
and acts a ‘stop-signal’ for the polymerase. In addition or as
an alternative the spatial arrangement of the catalytic
domains of WbdD relative to active site of site of WbdA
polymerase acts as a molecular ruler, which caps polymers
of a defined length.
Experimental procedures
Phenotypic analysis of E. coli O9a harbouring wbdD
site-directed mutations
CWG900 (DwbdD) (Clarke et al., 2009) harbouring pBAD24-
based plasmids expressing His6-tagged mutant derivatives of
wbdD were grown for 16 h at 37°C in LB broth containing
ampicillin (100 mg ml-1) and D-glucose (0.4% w/v). Five ml
volumes of LB broth containing ampicillin (100 mg ml-1) and
D-mannose (0.1% w/v) were inoculated 1:50 from the starter
cultures and incubated at 37°C until the OD600 achieved 0.4–
0.6. For SDS-PAGE, LPS was prepared from 1 OD600 unit of
cells by proteinase K treatment of whole-cell lysates (Hitch-
cock and Brown, 1983). SDS-PAGE was performed in Tris-
glycine buffer (Laemmli, 1970) and LPS was visualized by
silver staining (Tsai and Frasch, 1982).
Cloning and protein expression
The procedures used for the cloning, expression and purifi-
cation of WbdD556 have been described previously (Hage-
lueken et al., 2012). The WbdD459 construct was derived
from Wbd556 by introducing a stop codon at position 459
using site-directed mutagenesis (Liu and Naismith, 2008).
The expression and purification of WbdD459 were identical to
the procedures used for WbdD556 (Hagelueken et al., 2012).
Mutants of WbdD459 and WbdD556 were produced by site-
directed mutagenesis (Liu and Naismith, 2008). Expression
and purification procedures for the mutant proteins were
again identical to the wild-type constructs.
Crystallization, structure solution and refinement
WbdD556 was crystallized as previously reported (Hage-
lueken et al., 2012). Initial crystallization trials for WbdD459
were performed using a Honeybee 963 robot system
(Genomic Solutions), using both commercially available and
self-made (Oke et al., 2010) crystallization screens. For each
of the 96-well sitting-drop vapour-diffusion screens (MRC
plates, Greiner), 150 nl of protein solution (100 mg ml-1,
including 5 mM of each AMPPNP, SAM and MgCl2) was
mixed with 150 nl precipitant and equilibrated against a res-
ervoir of 75 ml of precipitant. The sealed plates were then
incubated at 293 K. Initial WbdD459 crystals were found in
condition 93 of the JCSG+ screen (Newman et al., 2005).
This condition was then optimized and best crystals (judged
by eye) were obtained from a mixture of 20.5% PEG 3350,
0.15 M magnesium chloride, 0.10 M Bis-Tris pH 5.5 and
5 mM of each AMPPNP and SAM. Crystals (~ 50–100 mm)
usually appeared after 4–5 days at 293 K. Co-crystals of
WbdD556 with kinase inhibitors were produced by soaking.
The compound was dissolved in DMSO (100 mM) and added
to the mother liquor of existing crystals. The plate was
re-sealed and incubated at room temperature overnight.
Soaked crystals were then treated with our previously
described dehydration and flash cooling procedure (Hage-
lueken et al., 2012) before diffraction data were collected.
Co-crystals of WbdD459 with D-Mannose were produced by
transferring the WbdD459 crystals to a saturated Mannose
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solution prior to flash cooling in liquid nitrogen for data
collection.
Diffraction data sets were collected using an in-house gen-
erator (Rigaku MicroMax™-007 HFM) and synchrotron
beamlines I04 and I04-1 at Diamond (Didcot, UK). Data sets
were processed using XIA2 (Winter, 2010) and structures
were solved by molecular replacement using the separate
domains of the low resolution WbdD556 structure as search
models for PHASER (McCoy et al., 2007). Structures were
refined with REFMAC5 (Murshudov et al., 1997), PHE-
NIX.REFINE (Adams et al., 2002) and COOT (Emsley and
Cowtan, 2004). The stereochemistry of the models was
evaluated with MOLPROBITY (Chen et al., 2010). Param-
eters of data collection, refinement and stereo chemical
parameters are listed in Table 1.
Data deposition: The atomic co-ordinates and structure
factors reported in this article have been deposited in Protein
Data Bank, http://www.pdb.org [PDB IDs: 4azs – 2.2A
WbdD556 structure; 4azt – WbdD556/LY294002; 4azv –
WbdD556/GW435821x; 4azw – WbdD459].
ADP production assay
The ADP-Glo kinase Assay Kit (Promega) was used to
analyse the kinetics of WbdD556 and WbdD459 with different
substrates, to compare the reactivity of mutant proteins and
to produce IC50 data. The reaction mix was prepared in a total
volume of 15 ml and contained 1 mM ATP, 1 mM enzyme and
substrate (e.g. 2 mM 2a-MB or 100 mM D-Mannose, see
Fig. 6 for concentrations that were used for enzyme kinetics)
in 1¥ kinase buffer (100 mM, Bis-Tris, pH 7.9, 100 mM NaCl
and 5 mM MgCl2). The mix was incubated inside an opaque
white 96-well plate (Greiner) at room temperature (RT) for
1.5 h with shaking. In the second step, 15 ml of ADP-Glo™
Reagent was added to each well and the plate was incubated
for another 40 min at RT with shaking. In the last step, 30 ml
of Kinase Detection Reagent was added to each well and the
plate was again incubated for 1 h at RT. The luminescence
was then recorded using a plate reader (Infinite® 200 PRO
NanoQuant, TECAN GROUP) and the data were analysed
with MS Excel and DataGraph (Visual Data Tools). To deter-
mine the IC50 values of kinase inhibitors, the compounds
(dissolved in DMSO) were added in a range of concentrations
(from 0.5 mM to 100 mM, Fig. 7) in the first step of the ADP-
GloTM experiment. All experiments were performed in at least
triplicate.
NMR
To analyse the kinase reaction of WbdD556 by NMR, 50 ml of
substrate (e.g. 2a-MB at 50 mM), 7 ml of ATP (100 mM), 3.5 ml
of MgCl2 (2 M) and 70 ml of D2O were adjusted to 700 ml with
kinase reaction buffer (100 mM Tris-HCl pH 7.9, 100 mM
NaCl, 5 mM MgCl2). The mixture was then transferred to a
standard NMR tube and 100 mg of WbdD556 in 50 ml of kinase
reaction buffer were added to the tube. The contents of the
tube was mixed by inverting the tube and the reaction was
followed at 37°C for several hours. To avoid ATP peaks in the
1H spectra, deuterated ATP (ATP-D6, SIGMA) was used in
some experiments. NMR spectra were acquired using a
Bruker AVANCE 500 instrument equipped with tuneable
broadband inverse (BBI) probe. To follow the MTase reaction,
the kinase reaction was set up in an NMR tube as above and
left to react overnight at 37°C. The 1H spectrum was recorded
to verify the completion of the kinase reaction before 70 ml of
100 mM SAM (SIGMA) and 100 mg of fresh WbdD556 (wild
type or mutants) in 50 ml of kinase reaction buffer were added.
To analyse the effect of sulphate on the reaction, 5.7 M ammo-
nium sulphate was added to a final concentration of 250 or
1.1 M sulphate. The MTase reaction was followed at 37°C.
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